Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Kevin Schuyler

Kevin Schuyler is recorded as Board Member at Twin Vee PowerCats, Co. (VEEE) and Chairman at Adial Pharmaceuticals, Inc. (ADIL). Twin Vee PowerCats, Co. reported in an 8-K filed November 12, 2024 that Kevin Schuyler was appointed Class III director, effective November 11, 2024. Adial Pharmaceuticals, Inc. reported in an 8-K filed August 23, 2022 that Kevin Schuyler was appointed non-executive Chairman of the board of directors, effective August 18, 2022. Twin Vee PowerCats, Co. reported in an 8-K filed July 6, 2022 that Kevin Schuyler was appointed Class III director, effective July 6, 2022.

“The following two (2) individuals were elected as Class III directors, to serve until the Company's 2027 annual meeting of stockholders and until their respective successors have been duly elected and qualified, with the following votes:”
Twin Vee PowerCats, Co. Form 8-K, filed November 12, 2024 · Read the filing
“On August 18, 2022, the Company’s board of directors also appointed Kevin Schuyler as non-executive Chairman of the board of directors.”
Adial Pharmaceuticals, Inc. Form 8-K, filed August 23, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Adial Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Twin Vee PowerCats, Co.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.